OpenFilings

REGENERON PHARMACEUTICALS, INC.

Form10-Q

Report Period2026-09-30

Date Filed2026-10-30

Time Filed06:55:31

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-Q
RESTRICTED STOCK PURCHASE AGREEMENT - THREE SEVENS HOLDING CORP
SIXTH AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT - SANOFI
INSIDER TRADING POLICY
CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)
CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)
CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350
Filing on SEC Edgar